title: [Goodpasture syndrome associated with p-ANCA microscopic vasculitis: a rare entity to recognize].
abstract: Some autoimmune diseases may be found presenting simultaneously antibodies (Abs) against basal membrane and anti-neutrophil cytoplasm (ANCA). The clinical picture is that of the Goodpasture syndrome with anti-basement membrane Abs associated with an ANCA-associated small-vessel vasculitis (micro-PAN). The arisen of these two pathological entities is nevertheless too frequent to be the fruit of the only fate. The pathophysiological hypothesis remains that of the micro-PAN initially creates lesions of the basement membrane facilitating the formation of Abs against some constituents of this latter. The prognosis remains controversial, leaving open this issue. This article aims to present a recent literature revue dealing with the simultaneous presence of these two auto-immune diseases.
authors.affiliation: Département de médecine, Centre hospitalier du centre du Valais, Hôpital de Sion, Sion. geraldine.pralong@rsv-gnw.ch
authors.forename: G
authors.initials: G
authors.lastname: Pralong
authors.forename: C
authors.initials: C
authors.lastname: Fournier
authors.forename: E
authors.initials: E
authors.lastname: Dayer
authors.forename: P
authors.initials: P
authors.lastname: Meier
mesh_terms: D019867:Anti-Glomerular Basement Membrane Disease / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology*; D019268:Antibodies, Antineutrophil Cytoplasmic / Q000276:immunology*; D001323:Autoantibodies / Q000276:immunology; D015415:Biomarkers / Q000378:metabolism; D048909:Diabetes Complications; D006801:Humans; D007155:Immunologic Factors / Q000276:immunology*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D016896:Treatment Outcome; D014657:Vasculitis / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology*
chemical_list: D019268:Antibodies, Antineutrophil Cytoplasmic; D001323:Autoantibodies; D015415:Biomarkers; D007155:Immunologic Factors; D007166:Immunosuppressive Agents